Related references
Note: Only part of the references are listed.A prospective longitudinal study on the microbiota composition in amyotrophic lateral sclerosis
Diana Di Gioia et al.
BMC MEDICINE (2020)
Immunity in amyotrophic lateral sclerosis: blurred lines between excessive inflammation and inefficient immune responses
Louis-Charles Beland et al.
BRAIN COMMUNICATIONS (2020)
Revised Airlie House consensus guidelines for design and implementation of ALS clinical trials
Leonard H. van den Berg et al.
NEUROLOGY (2019)
ESPEN guideline clinical nutrition in neurology
Rosa Burgos et al.
CLINICAL NUTRITION (2018)
Hypermetabolism in ALS is associated with greater functional decline and shorter survival
Frederik J. Steyn et al.
JOURNAL OF NEUROLOGY NEUROSURGERY AND PSYCHIATRY (2018)
β-Hydroxybutyrate Deactivates Neutrophil NLRP3 Inflammasome to Relieve Gout Flares
Emily L. Goldberg et al.
CELL REPORTS (2017)
Triheptanoin Protects Motor Neurons and Delays the Onset of Motor Symptoms in a Mouse Model of Amyotrophic Lateral Sclerosis
Tesfaye W. Tefera et al.
PLOS ONE (2016)
Effects of ketone bodies in Alzheimer's disease in relation to neural hypometabolism, -amyloid toxicity, and astrocyte function
Leif Hertz et al.
JOURNAL OF NEUROCHEMISTRY (2015)
The ketone metabolite β-hydroxybutyrate blocks NLRP3 inflammasome-mediated inflammatory disease
Yun-Hee Youm et al.
NATURE MEDICINE (2015)
Metabolic Therapy with Deanna Protocol Supplementation Delays Disease Progression and Extends Survival in Amyotrophic Lateral Sclerosis (ALS) Mouse Model
Csilla Ari et al.
PLOS ONE (2014)
Niacin Increases Adiponectin and Decreases Adipose Tissue Inflammation in High Fat Diet-Fed Mice
Desiree Wanders et al.
PLOS ONE (2013)
Mind-altering microorganisms: the impact of the gut microbiota on brain and behaviour
John F. Cryan et al.
NATURE REVIEWS NEUROSCIENCE (2012)
Caprylic Triglyceride as a Novel Therapeutic Approach to Effectively Improve the Performance and Attenuate the Symptoms Due to the Motor Neuron Loss in ALS Disease
Wei Zhao et al.
PLOS ONE (2012)
The ketogenic diet as a treatment paradigm for diverse neurological disorders
Carl E. Stafstrom et al.
FRONTIERS IN PHARMACOLOGY (2012)
Nicotinic acid inhibits progression of atherosclerosis in mice through its receptor GPR109A expressed by immune cells
Martina Lukasova et al.
JOURNAL OF CLINICAL INVESTIGATION (2011)
Ketogenic Diet Prevents Alterations in Brain Metabolism in Young but not Adult Rats after Traumatic Brain Injury
Ying Deng-Bryant et al.
JOURNAL OF NEUROTRAUMA (2011)
Amyotrophic lateral sclerosis
Matthew C. Kiernan et al.
LANCET (2011)
Principles and clinical implications of the brain-gut-enteric microbiota axis
Sang H. Rhee et al.
NATURE REVIEWS GASTROENTEROLOGY & HEPATOLOGY (2009)
Reduced Pain and Inflammation in Juvenile and Adult Rats Fed a Ketogenic Diet
David N. Ruskin et al.
PLOS ONE (2009)
Familial ALS-superoxide dismutases associate with mitochondria and shift their redox potentials
Alberto Ferri et al.
PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA (2006)
A ketogenic diet as a potential novel therapeutic intervention in amyotrophic lateral sclerosis
Zhong Zhao et al.
BMC NEUROSCIENCE (2006)
Neuroprotective and disease-modifying effects of the ketogenic diet
Maciej Gasior et al.
BEHAVIOURAL PHARMACOLOGY (2006)
Mitochondrial involvement in amyotrophic lateral sclerosis
FM Menzies et al.
NEUROCHEMISTRY INTERNATIONAL (2002)
Share Paper
